Literature DB >> 16531554

Immunoadsorption and CD20 antibody treatment in a patient with treatment resistant systemic lupus erythematosus and preterminal renal insufficiency.

J Rech, A J Hueber, S Kallert, C Requadt, J R Kalden, H Schulze-Koops.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16531554      PMCID： PMC1798078          DOI： 10.1136/ard.2005.043026

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  5 in total

1.  Failure of rituximab to treat a lupus flare-up with nephritis.

Authors:  O Lambotte; A Dürbach; R Kotb; S Ferlicot; J F Delfraissy; C Goujard
Journal:  Clin Nephrol       Date:  2005-07       Impact factor: 0.975

2.  An open study of B lymphocyte depletion in systemic lupus erythematosus.

Authors:  Maria J Leandro; Jonathan C Edwards; Geraldine Cambridge; Michael R Ehrenstein; David A Isenberg
Journal:  Arthritis Rheum       Date:  2002-10

3.  Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases.

Authors:  J-E Gottenberg; L Guillevin; O Lambotte; B Combe; Y Allanore; A Cantagrel; C Larroche; M Soubrier; L Bouillet; M Dougados; O Fain; D Farge; X Kyndt; O Lortholary; C Masson; B Moura; P Remy; T Thomas; D Wendling; J-M Anaya; J Sibilia; X Mariette
Journal:  Ann Rheum Dis       Date:  2004-11-18       Impact factor: 19.103

4.  Immunoadsorption therapy (therasorb) in patients with severe lupus erythematosus.

Authors:  Monika Graninger; Sabine Schmaldienst; K Derfler; W B Graninger
Journal:  Acta Med Austriaca       Date:  2002

Review 5.  Anti B cell therapy (rituximab) in the treatment of autoimmune diseases.

Authors:  Hanadi Kazkaz; David Isenberg
Journal:  Curr Opin Pharmacol       Date:  2004-08       Impact factor: 5.547
  5 in total
  2 in total

Review 1.  Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007.

Authors:  D E Furst; F C Breedveld; J R Kalden; J S Smolen; G R Burmester; J Sieper; P Emery; E C Keystone; M H Schiff; P Mease; P L C M van Riel; R Fleischmann; M H Weisman; M E Weinblatt
Journal:  Ann Rheum Dis       Date:  2007-11       Impact factor: 19.103

2.  Rapid reduction of antibodies and improvement of disease activity by immunoadsorption in Chinese patients with severe systemic lupus erythematosus.

Authors:  Jinxian Huang; Guoxiang Song; Zhihua Yin; Weizhen He; Lijun Zhang; Weihong Kong; Zhizhong Ye
Journal:  Clin Rheumatol       Date:  2016-08-03       Impact factor: 2.980
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.